JP2022538541A5 - - Google Patents
Info
- Publication number
- JP2022538541A5 JP2022538541A5 JP2021575325A JP2021575325A JP2022538541A5 JP 2022538541 A5 JP2022538541 A5 JP 2022538541A5 JP 2021575325 A JP2021575325 A JP 2021575325A JP 2021575325 A JP2021575325 A JP 2021575325A JP 2022538541 A5 JP2022538541 A5 JP 2022538541A5
- Authority
- JP
- Japan
- Prior art keywords
- difluoropropyl
- phenoxy
- bromo
- acid
- cycloalkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19181270.0 | 2019-06-19 | ||
| EP19181270 | 2019-06-19 | ||
| PCT/EP2020/067072 WO2020254559A1 (en) | 2019-06-19 | 2020-06-19 | Compounds for the treatment of neuromuscular disorders |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022538541A JP2022538541A (ja) | 2022-09-05 |
| JP2022538541A5 true JP2022538541A5 (https=) | 2023-06-28 |
| JP7662196B2 JP7662196B2 (ja) | 2025-04-15 |
Family
ID=66999610
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021575325A Active JP7662196B2 (ja) | 2019-06-19 | 2020-06-19 | 神経筋障害の治療のための化合物 |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US12415771B2 (https=) |
| EP (1) | EP3986852B1 (https=) |
| JP (1) | JP7662196B2 (https=) |
| KR (1) | KR102822753B1 (https=) |
| CN (1) | CN114008012B (https=) |
| AR (1) | AR119199A1 (https=) |
| AU (1) | AU2020298088B2 (https=) |
| BR (1) | BR112021025637A2 (https=) |
| CA (1) | CA3138332A1 (https=) |
| CL (1) | CL2021003318A1 (https=) |
| CO (1) | CO2021016931A2 (https=) |
| IL (1) | IL288234B2 (https=) |
| MA (1) | MA56501A (https=) |
| MX (1) | MX2021013508A (https=) |
| PE (1) | PE20220391A1 (https=) |
| PH (1) | PH12021552771A1 (https=) |
| SA (1) | SA521431094B1 (https=) |
| SG (1) | SG11202112250QA (https=) |
| TW (1) | TW202114977A (https=) |
| WO (1) | WO2020254559A1 (https=) |
| ZA (1) | ZA202108083B (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20260007625A1 (en) | 2022-09-15 | 2026-01-08 | Nmd Pharma A/S | Compounds for the Treatment of Neuromuscular Disorders |
| EP4731200A1 (en) | 2023-06-20 | 2026-04-29 | NMD Pharma A/S | Clc-1 inhibitors for use in the treatment of multiple sclerosis and neuromuscular diseases |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3709926A (en) * | 1971-02-01 | 1973-01-09 | Dow Chemical Co | Substituted phenoxy-alkanoic acids and derivatives thereof |
| IL111613A0 (en) * | 1993-11-12 | 1995-01-24 | Rhone Poulenc Rorer Ltd | Substituted phenyl compounds, their preparation and pharmaceutical compositions containing them |
| US6558414B2 (en) * | 1999-02-02 | 2003-05-06 | Impra, Inc. | Partial encapsulation of stents using strips and bands |
| SE0301009D0 (sv) | 2003-04-07 | 2003-04-07 | Astrazeneca Ab | Novel compounds |
| GB0409921D0 (en) | 2004-05-04 | 2004-06-09 | Novartis Ag | Organic compounds |
| GB0422057D0 (en) | 2004-10-05 | 2004-11-03 | Astrazeneca Ab | Novel compounds |
| UY29223A1 (es) | 2004-11-23 | 2006-06-30 | Astrazeneca Ab | Ácidos fenoxiacéticos sustituidos, composiciones farmacéuticas que los contienen y procesos para su preparación |
| TW200745003A (en) | 2005-10-06 | 2007-12-16 | Astrazeneca Ab | Novel compounds |
| WO2007062678A1 (en) | 2005-11-29 | 2007-06-07 | 7Tm Pharma A/S | Phenoxyacetic acid derivatives as crth2 receptor ligands |
| GB0524428D0 (en) | 2005-11-30 | 2006-01-11 | 7Tm Pharma As | Medicinal use of receptor ligands |
| US9133123B2 (en) | 2010-04-23 | 2015-09-15 | Cytokinetics, Inc. | Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use |
| MX389242B (es) | 2015-06-15 | 2025-03-20 | Nmd Pharma As | Compuestos para su uso en el tratamiento de trastornos neuromusculares |
| US11730714B2 (en) | 2017-12-14 | 2023-08-22 | Nmd Pharma A/S | Compounds for the treatment of neuromuscular disorders |
| US11591284B2 (en) | 2017-12-14 | 2023-02-28 | Nmd Pharma A/S | Compounds for the treatment of neuromuscular disorders |
| TWI794369B (zh) | 2017-12-14 | 2023-03-01 | 丹麥商Ｎｍｄ藥品公司 | 用於治療神經肌肉病症的化合物 |
| US11147788B2 (en) | 2017-12-14 | 2021-10-19 | Nmd Pharma A/S | Compounds for the treatment of neuromuscular disorders |
| US20190183812A1 (en) | 2017-12-14 | 2019-06-20 | Nmd Pharma A/S | Compounds For The Treatment Of Neuromuscular Disorders |
| US10385028B2 (en) * | 2017-12-14 | 2019-08-20 | Nmd Pharma A/S | Compounds for the treatment of neuromuscular disorders |
| TW201927738A (zh) | 2017-12-14 | 2019-07-16 | 丹麥商Ｎｍｄ藥品公司 | 用於治療神經肌肉病症的化合物 |
| JP2022516555A (ja) | 2019-01-04 | 2022-02-28 | プラクシス バイオテック エルエルシー | 線維芽細胞活性化タンパク質の阻害剤 |
| BR112021025655A2 (pt) | 2019-06-19 | 2022-02-01 | Viiv Healthcare Uk No 5 Ltd | Inibidores da replicação do vírus da imunodeficiência humana |
| WO2020257487A1 (en) | 2019-06-19 | 2020-12-24 | Biomarin Pharmaceutical Inc. | Glycolate oxidase inhibitors for the treatment of disease |
-
2020
- 2020-06-19 BR BR112021025637A patent/BR112021025637A2/pt not_active Application Discontinuation
- 2020-06-19 TW TW109120913A patent/TW202114977A/zh unknown
- 2020-06-19 PE PE2021001997A patent/PE20220391A1/es unknown
- 2020-06-19 MA MA056501A patent/MA56501A/fr unknown
- 2020-06-19 PH PH1/2021/552771A patent/PH12021552771A1/en unknown
- 2020-06-19 MX MX2021013508A patent/MX2021013508A/es unknown
- 2020-06-19 AU AU2020298088A patent/AU2020298088B2/en active Active
- 2020-06-19 CN CN202080044543.7A patent/CN114008012B/zh active Active
- 2020-06-19 US US17/620,294 patent/US12415771B2/en active Active
- 2020-06-19 CA CA3138332A patent/CA3138332A1/en active Pending
- 2020-06-19 SG SG11202112250QA patent/SG11202112250QA/en unknown
- 2020-06-19 WO PCT/EP2020/067072 patent/WO2020254559A1/en not_active Ceased
- 2020-06-19 JP JP2021575325A patent/JP7662196B2/ja active Active
- 2020-06-19 IL IL288234A patent/IL288234B2/en unknown
- 2020-06-19 AR ARP200101736A patent/AR119199A1/es not_active Application Discontinuation
- 2020-06-19 EP EP20732951.7A patent/EP3986852B1/en active Active
- 2020-06-19 KR KR1020217038226A patent/KR102822753B1/ko active Active
-
2021
- 2021-10-21 ZA ZA2021/08083A patent/ZA202108083B/en unknown
- 2021-12-13 SA SA521431094A patent/SA521431094B1/ar unknown
- 2021-12-13 CL CL2021003318A patent/CL2021003318A1/es unknown
- 2021-12-14 CO CONC2021/0016931A patent/CO2021016931A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2008110949A (ru) | Соединения и композиции-иммуносупрессанты | |
| RU2440330C2 (ru) | ПРОИЗВОДНЫЕ 4-(2-АМИНО-1-ГИДРОКСИЭТИЛ)ФЕНОЛА, КАК АГОНИСТЫ β2 АДРЕНЕРГИЧЕСКОГО РЕЦЕПТОРА | |
| JP2017526636A5 (https=) | ||
| JP2006077019A5 (https=) | ||
| JP2007502806A5 (https=) | ||
| JP2022538541A5 (https=) | ||
| RU2006107653A (ru) | Связующее вспомогательное вещество и приготовленная на его основе таблетка в форме капли | |
| AU2019283837B2 (en) | Ppar agonists, compounds, pharmaceutical compositions, and methods of use thereof | |
| JP2007525516A5 (https=) | ||
| JP2011523647A5 (https=) | ||
| CA2601508A1 (en) | Cyclopropanecarboxamide derivatives | |
| NZ603594A (en) | Certain amino-pyrimidines, compositions thereof, and methods for their use | |
| JP2009544602A5 (https=) | ||
| JP2009537595A5 (https=) | ||
| RU2010107169A (ru) | Фармацевтическая композиция, содержащая оптически активное соединение, обладающее активностью агониста рецептора тромбопоэтина, и промежуточное соединение для этого | |
| JP2024518556A5 (https=) | ||
| JP2010527985A5 (https=) | ||
| JP2019501948A5 (https=) | ||
| IL274744B2 (en) | Phenoxy acids for the treatment of neuromuscular disorders | |
| JP2017513892A5 (https=) | ||
| JP2025504963A5 (https=) | ||
| JP2009501745A5 (https=) | ||
| JP2023547346A5 (https=) | ||
| JP2009514899A5 (https=) | ||
| ZA200209152B (en) | Heterocyclic compounds. |